The North America intraoperative neuromonitoring market is expected to reach US$ 1,874.02 million by 2027 from US$ 1,029.17 million in 2019; it is estimated to grow at a CAGR of 7.9% from 2019 to 2027.
The intraoperative neuromonitoring market in North America grows primarily due to rising incidences of neurological disorders and increasing technological advancements in the field of neuromonitoring; however, the lack of skilled professionals restrains the growth of the market. Additionally, increasing research activities in nerve monitoring field and integration of artificial intelligence (AI) technology with neuromonitoring are expected to fuel the growth of the intraoperative neuromonitoring market during the forecast period.
Intraoperative neurophysiological monitoring (IOM), an integral part of most of the surgical procedures, prevents the neurological damage that may cause during surgeries.It also identifies the neural structures, thereby preventing the post-operative impairments.
IOM employs a wide range of modalities such as motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), electroencephalography (EEG), electromyography, brainstem auditory evoked potentials (BAEPs), and visual evoked potentials (VEPs).
Neuromonitoring provides real-time alerts during the surgery and helps the surgeon make informed decisions to avoid neural injuries; also, many integrated technologies enhance the patient outcome. Many studies demonstrate that a combination of advanced optical imaging with an AI algorithm generate an accurate, real-time intraoperative diagnosis of brain tumors.
For instance, Nervio has developed an innovative, autonomous, and intraoperative neuromonitoring solution by using AI technology.The system offers real-time alerts and clinical recommendations during the surgery.
The company aims to make neuromonitoring accessible and affordable.Moreover, Al is increasingly being utilized in treating neurological disorders.
For example, in October 2019, Henry Ford Health System and Mon4t launched a pilot study related to AI and Parkinson’s disease. Thus, these innovations drive the growth of the market.
The patients who go through critical surgeries such as spinal surgery, neurosurgery, or ENT surgery need physical attention and are required to undergo a few procedures in clinics/hospitals.The procedures include intraoperative neuromonitoring by systems, services, and accessories.
During surgical treatments and other procedures, doctors and healthcare specialists are in direct contact with patients.Due to the ongoing COVID-19 pandemic situation in North America, it is crucial to maintain social distancing in order to avoid direct exposure to body fluids.
Considering these facts, many hospitals and clinics are hesitating to schedule these surgeries unless it is critical. Therefore, this scenario affects the growth of the intraoperative neuromonitoring market in North America.
In 2019, the systems segment accounted for the largest share of the North America intraoperative neuromonitoring market.Systems in intraoperative monitoring have become a crucial factor in neurosurgery as these offer an early warning concerning motor and sensory functions during surgery, thus it yields better results and avoids post-operative neurophysiological deficits.
Moreover, market players are continuously developing advanced products to gain high market share. A few major secondary sources referred to while preparing the North America intraoperative neuromonitoring market report are World Health Organization (WHO), Centers of Disease Control and Prevention (CDC), Orthopaedic Research Society, Canadian Patient Safety Institute (CPSI), and American Association of Neurological Surgeons.
Our reports have been used by over 10K customers, including:
The global remote patient monitoring market is expected to reach US$ 188,952.22 million by 2028 from US$ 29,062.30 million in 2021. The market is estimated to grow at a CAGR of 30.7% from 2021 to 2028. The key factors that are driving the growth of market are the growing prevalence of chronic diseases, rising awareness regarding healthcare,...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Medication Management Market Report The global medication management market by revenue is expected to grow at a CAGR of over 15.15% during the period 2020–2026. With the high adoption of IT in the healthcare industry globally, there...
The North America smart baby monitor market is expected to grow from US$ 439.47 million in 2020 to US$ 752.48 million by 2028; it is estimated to grow at a CAGR of 7% 2020-2028. The increasing number of corporate daycare/childcare centers is expected to surge the North America smart baby monitor market. Several governments support the growth...
The smart baby monitor market is expected to grow from US$ 989.38 in 2020 to US$ 1,815.31 million by 2028; it is estimated to grow at a CAGR of 8.0% from 2021 to 2028. Increasing number of working parents worldwide is boosting the growth of the smart baby monitor market globally.The growing number of nuclear families and working parents...
212 pages •
By Asia Market Information & Development Company
• Feb 2021
China’s demand for Patient Monitoring and Diagnostic Systems has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import...
108 pages •
By Asia Market Information & Development Company
• Feb 2021
This study focuses on China’s Patient Monitoring and Diagnostic Systems industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is...
The patient monitoring devices market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6% during the forecast period. Growth of the market is mainly attributed to the technological advancements; increasing incidences of infectious diseases, and growing public and private investments, funding, and...
The global remote patient monitoring market is projected to reach USD 117.1 billion by 2025 from USD 23.2 billion in 2020, at a CAGR of 38.2% between 2020 and 2025. The rising geriatric population and the growing need to expand healthcare access, cost benefits of telehealth and remote patient monitoring, benefits of RPM to reduce the burden...
The North America automated dispensing systems market accounted to US$ 814.69 million in 2019 and is anticipated to grow at a CAGR of 7.8% to account for US$ 1,479.76 million by 2027. The growth of North America automated dispensing systems market is attributed to the factors such as large usage of automated dispensing systems in pharmacies,...
The global multiparameter patient monitoring market is expected to grow at a CAGR of over 4% during the period 2019–2025. The following factors are likely to contribute to the growth of the multiparameter patient monitoring market during the forecast period: • Growing Demand for Real-time Patient Monitors in Critical Care • Increasing...
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.